255 related articles for article (PubMed ID: 28861715)
1. The neuroprotective transcription factor ATF5 is decreased and sequestered into polyglutamine inclusions in Huntington's disease.
Hernández IH; Torres-Peraza J; Santos-Galindo M; Ramos-Morón E; Fernández-Fernández MR; Pérez-Álvarez MJ; Miranda-Vizuete A; Lucas JJ
Acta Neuropathol; 2017 Dec; 134(6):839-850. PubMed ID: 28861715
[TBL] [Abstract][Full Text] [Related]
2. Protective neuronal induction of ATF5 in endoplasmic reticulum stress induced by status epilepticus.
Torres-Peraza JF; Engel T; Martín-Ibáñez R; Sanz-Rodríguez A; Fernández-Fernández MR; Esgleas M; Canals JM; Henshall DC; Lucas JJ
Brain; 2013 Apr; 136(Pt 4):1161-76. PubMed ID: 23518711
[TBL] [Abstract][Full Text] [Related]
3. Huntingtin inclusions do not deplete polyglutamine-containing transcription factors in HD mice.
Yu ZX; Li SH; Nguyen HP; Li XJ
Hum Mol Genet; 2002 Apr; 11(8):905-14. PubMed ID: 11971872
[TBL] [Abstract][Full Text] [Related]
4. Reduced Expression of Foxp1 as a Contributing Factor in Huntington's Disease.
Louis Sam Titus ASC; Yusuff T; Cassar M; Thomas E; Kretzschmar D; D'Mello SR
J Neurosci; 2017 Jul; 37(27):6575-6587. PubMed ID: 28550168
[TBL] [Abstract][Full Text] [Related]
5. AAV-mediated delivery of the transcription factor XBP1s into the striatum reduces mutant Huntingtin aggregation in a mouse model of Huntington's disease.
Zuleta A; Vidal RL; Armentano D; Parsons G; Hetz C
Biochem Biophys Res Commun; 2012 Apr; 420(3):558-63. PubMed ID: 22445760
[TBL] [Abstract][Full Text] [Related]
6. Small molecule modulator of protein disulfide isomerase attenuates mutant huntingtin toxicity and inhibits endoplasmic reticulum stress in a mouse model of Huntington's disease.
Zhou X; Li G; Kaplan A; Gaschler MM; Zhang X; Hou Z; Jiang M; Zott R; Cremers S; Stockwell BR; Duan W
Hum Mol Genet; 2018 May; 27(9):1545-1555. PubMed ID: 29462355
[TBL] [Abstract][Full Text] [Related]
7. Frequency of nuclear mutant huntingtin inclusion formation in neurons and glia is cell-type-specific.
Jansen AH; van Hal M; Op den Kelder IC; Meier RT; de Ruiter AA; Schut MH; Smith DL; Grit C; Brouwer N; Kamphuis W; Boddeke HW; den Dunnen WF; van Roon WM; Bates GP; Hol EM; Reits EA
Glia; 2017 Jan; 65(1):50-61. PubMed ID: 27615381
[TBL] [Abstract][Full Text] [Related]
8. Differential contributions of Caenorhabditis elegans histone deacetylases to huntingtin polyglutamine toxicity.
Bates EA; Victor M; Jones AK; Shi Y; Hart AC
J Neurosci; 2006 Mar; 26(10):2830-8. PubMed ID: 16525063
[TBL] [Abstract][Full Text] [Related]
9. Targeting the UPR transcription factor XBP1 protects against Huntington's disease through the regulation of FoxO1 and autophagy.
Vidal RL; Figueroa A; Court FA; Thielen P; Molina C; Wirth C; Caballero B; Kiffin R; Segura-Aguilar J; Cuervo AM; Glimcher LH; Hetz C
Hum Mol Genet; 2012 May; 21(10):2245-62. PubMed ID: 22337954
[TBL] [Abstract][Full Text] [Related]
10. The endoplasmic reticulum stress transducer BBF2H7 suppresses apoptosis by activating the ATF5-MCL1 pathway in growth plate cartilage.
Izumi S; Saito A; Kanemoto S; Kawasaki N; Asada R; Iwamoto H; Oki M; Miyagi H; Ochi M; Imaizumi K
J Biol Chem; 2012 Oct; 287(43):36190-200. PubMed ID: 22936798
[TBL] [Abstract][Full Text] [Related]
11. α-Synuclein accumulates in huntingtin inclusions but forms independent filaments and its deficiency attenuates early phenotype in a mouse model of Huntington's disease.
Tomás-Zapico C; Díez-Zaera M; Ferrer I; Gómez-Ramos P; Morán MA; Miras-Portugal MT; Díaz-Hernández M; Lucas JJ
Hum Mol Genet; 2012 Feb; 21(3):495-510. PubMed ID: 22045698
[TBL] [Abstract][Full Text] [Related]
12. Endoplasmic reticulum stress: The cause and solution to Huntington's disease?
Jiang Y; Chadwick SR; Lajoie P
Brain Res; 2016 Oct; 1648(Pt B):650-657. PubMed ID: 27040914
[TBL] [Abstract][Full Text] [Related]
13. Pridopidine protects neurons from mutant-huntingtin toxicity via the sigma-1 receptor.
Eddings CR; Arbez N; Akimov S; Geva M; Hayden MR; Ross CA
Neurobiol Dis; 2019 Sep; 129():118-129. PubMed ID: 31108174
[TBL] [Abstract][Full Text] [Related]
14. Differential morphology and composition of inclusions in the R6/2 mouse and PC12 cell models of Huntington's disease.
Wanderer J; Morton AJ
Histochem Cell Biol; 2007 May; 127(5):473-84. PubMed ID: 17285342
[TBL] [Abstract][Full Text] [Related]
15. Reduction of polyglutamine toxicity by TDP-43, FUS and progranulin in Huntington's disease models.
Tauffenberger A; Chitramuthu BP; Bateman A; Bennett HP; Parker JA
Hum Mol Genet; 2013 Feb; 22(4):782-94. PubMed ID: 23172908
[TBL] [Abstract][Full Text] [Related]
16. Adenovirus vector-based in vitro neuronal cell model for Huntington's disease with human disease-like differential aggregation and degeneration.
Dong X; Zong S; Witting A; Lindenberg KS; Kochanek S; Huang B
J Gene Med; 2012 Jul; 14(7):468-81. PubMed ID: 22700462
[TBL] [Abstract][Full Text] [Related]
17. Cystamine increases L-cysteine levels in Huntington's disease transgenic mouse brain and in a PC12 model of polyglutamine aggregation.
Fox JH; Barber DS; Singh B; Zucker B; Swindell MK; Norflus F; Buzescu R; Chopra R; Ferrante RJ; Kazantsev A; Hersch SM
J Neurochem; 2004 Oct; 91(2):413-22. PubMed ID: 15447674
[TBL] [Abstract][Full Text] [Related]
18. Dynamic recruitment of active proteasomes into polyglutamine initiated inclusion bodies.
Schipper-Krom S; Juenemann K; Jansen AH; Wiemhoefer A; van den Nieuwendijk R; Smith DL; Hink MA; Bates GP; Overkleeft H; Ovaa H; Reits E
FEBS Lett; 2014 Jan; 588(1):151-9. PubMed ID: 24291262
[TBL] [Abstract][Full Text] [Related]
19. Mutant huntingtin and glycogen synthase kinase 3-beta accumulate in neuronal lipid rafts of a presymptomatic knock-in mouse model of Huntington's disease.
Valencia A; Reeves PB; Sapp E; Li X; Alexander J; Kegel KB; Chase K; Aronin N; DiFiglia M
J Neurosci Res; 2010 Jan; 88(1):179-90. PubMed ID: 19642201
[TBL] [Abstract][Full Text] [Related]
20. Selenium Nanoparticles as an Efficient Nanomedicine for the Therapy of Huntington's Disease.
Cong W; Bai R; Li YF; Wang L; Chen C
ACS Appl Mater Interfaces; 2019 Sep; 11(38):34725-34735. PubMed ID: 31479233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
